Related Experiment Video
Updated: Oct 1, 2025

09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.1K
Phytochemical-loaded liposomes for anticancer therapy: an updated review
Vivek P Chavda1, Disha Vihol2, Bhavya Mehta2
1Department of Pharmaceutics & Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, 380009, India.
Nanomedicine (London, England)
|March 9, 2022
Summary
Liposomal nanovesicles enhance the delivery of anticancer phytochemicals, overcoming limitations like poor bioavailability and targeting issues in cancer therapy. This approach improves therapeutic effectiveness for natural compounds against cancer.
Area of Science:
- Pharmacology
- Nanotechnology
- Natural Product Chemistry
Background:
- Current chemotherapy faces challenges including severe adverse effects, narrow therapeutic indexes, and multidrug resistance.
- Anticancer phytochemicals from natural plants offer alternative therapies but suffer from poor bioavailability and non-specific targeting.
- These limitations reduce the clinical efficacy of promising natural anticancer agents.
Purpose of the Study:
- To review liposomal nanovesicle approaches for delivering anticancer phytochemicals.
- To discuss recent advances in liposomal formulations for cancer phytotherapy.
- To highlight strategies for improving the therapeutic effectiveness of phytochemicals.
Main Methods:
- Literature review of scientific publications on liposomal delivery systems for phytochemicals.
- Analysis of studies focusing on overcoming bioavailability and targeting challenges.
- Evaluation of recent advancements in cancer phytotherapy using nanovesicular formulations.
Main Results:
- Liposomal nanovesicles improve the delivery of anticancer phytochemicals by enhancing cell barrier transport.
- These formulations offer improved cancer-specific targeting capabilities.
- Liposomal encapsulation addresses issues of poor bioavailability and high dose requirements for phytochemicals.
Conclusions:
- Liposomal nanovesicles represent a promising strategy to enhance the efficacy of anticancer phytochemicals.
- This approach effectively tackles major limitations associated with natural anticancer compounds.
- Further research into liposomal phytotherapy holds significant potential for improved cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

